Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;53(7):753-8.
doi: 10.3345/kjp.2010.53.7.753. Epub 2010 Jul 31.

Effect of p16 on glucocorticoid response in a B-cell lymphoblast cell line

Affiliations

Effect of p16 on glucocorticoid response in a B-cell lymphoblast cell line

Sun-Young Kim et al. Korean J Pediatr. 2010 Jul.

Abstract

Purpose: It has been suggested that p16 has a role in glucocorticoid (GC)-related apoptosis in leukemic cells, but the exact mechanisms have yet to be clarified. We evaluated the relationship between the GC response and p16 expression in a lymphoma cell line.

Methods: We used p16 siRNA transfection to construct p16-inactivated cells by using the B-cell lymphoblast cell line NC-37. We compared glucocorticoid receptor (GR) expression, apoptosis, and cell viability between control (p16+ NC-37) and p16 siRNA-transfected (p16- NC-37) cells after a single dose of dexamethasone (DX).

Results: In both groups, there was a significant increase in cytoplasmic GR expression, which tended to be higher for p16+ NC-37 cells than for p16- NC37 cells at all times, and the difference at 18 h was significant (P<0.05). Similar patterns of early apoptosis were observed in both groups, and late apoptosis occurred at higher levels at 18 h when the GR had already been downregulated (P<0.05). Cell viability decreased in both groups but the degree of reduction was more severe in p16+ NC-37 cells after 18 h (P<0.05).

Conclusion: These results suggest a relationship between GR expression and cell cycle inhibition, in which the absence of p16 leads to reduced cell sensitivity to DX.

Keywords: Glucocorticoid; Lymphoblast; p16.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Western blot analysis of p16 compared with β-actin in NC-37 cells. Wild-type, control siRNA-transfected, and p16 siRNA-transfected NC-37 cells were immunoblotted with p16 antibody. The p16 siRNA-transfected NC-37 cells did not express p16 protein. The bar graphs express the ratio of p16 to β-actin calculated from densitometry measurements. *P<0.05.
Fig. 2
Fig. 2
Cytoplasmic glucocorticoid receptor (GR) expression levels as measured by flow cytometry. Time-dependent changes in GR expression after dexamethasone (DX) treatment are shown for control and p16 siRNA-transfected NC-37 (A) along with the results of flow cytometry (B). GR expression peaked at 18 h and decreased sharply at 24 h. The control NC-37 cells expressed higher glucocorticoid receptor (GR) levels compared to the p16 siRNA-transfected NC-37 cells at 18 h. *P<0.05.
Fig. 3
Fig. 3
Apoptotic cells stained with annexin V and propidium iodide (PI) as assessed by flow cytometry in both groups. Annexin V single-positive cells were regarded as early apoptotic cells (A) and double-positive cells were regarded as late apoptotic cells (B). There were no statistical differences between the 2 groups for early apoptosis (A). Late apoptotic cells increased in a time-dependent manner and peaked at 18 h in the control NC-37 cells. *P<0.05.
Fig. 4
Fig. 4
Alamar blue (AB) assay estimating time-dependent cell viability. Cell viability decreased after dexamethasone (DX) treatment. After 12 h, viability of the control NC-37 cells decreased more rapidly than that of the p16 siRNA-transfected NC-37 cells. *P<0.05.

References

    1. Biondi A, Valsecchi MG, Seriu T, D'Aniello E, Willemse MJ, Fasching K, et al. Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM Study Group. Leukemia. 2000;14:1939–1943. - PubMed
    1. Myoumoto A, Nakatani K, Koshimizu TA, Matsubara H, Adachi S, Tsujimoto G. Glucocorticoid-induced granzyme A expression can be used as a marker of glucocorticoid sensitivity for acute lymphoblastic leukemia therapy. J Hum Genet. 2007;52:328–333. - PubMed
    1. Tutor O, Díaz MA, Ramírez M, Algara P, Madero L, Martínez P. Loss of heterozygosity of p16 correlates with minimal residual disease at the end of the induction therapy in non-high risk childhood B-cell precursor acute lymphoblastic leukemia. Leuk Res. 2002;26:817–820. - PubMed
    1. Frankfurt O, Rosen ST. Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol. 2004;16:553–563. - PubMed
    1. Renner K, Ausserlechner MJ, Kofler R. A conceptual view on glucocorticoid-induced apoptosis, cell cycle arrest and glucocorticoid resistance in lymphoblastic leukemia. Curr Mol Med. 2003;3:707–717. - PubMed

LinkOut - more resources